Abstract
The objective of this open single-centre study was to evaluate the efficacy and tolerability of botulinum toxin type-A (BTX-A) as add-on in the prophylactic treatment of cluster headache (CH). Twelve male patients with episodic (n=3) or chronic (n=9) CH, unresponsive to common prophylactic medications, were treated with a cumulative dose of 50 International Units (IU) BTX-A according to a standardised injection scheme into the ipsilateral pericranial muscles. One patient with chronic CH experienced a total cessation of attacks and in 2 patients attack intensity and frequency improved. In another patient with chronic CH typical attacks were not influenced, but an ipsilateral continuous occipital headache significantly improved. Patients with episodic CH did not benefit from BTX-A treatment. Tolerability was excellent. These findings provide evidence that BTX-A may be beneficial as an add-on prophylactic therapy for a limited number of patients with chronic CH.
References
Russel MB (2004) Epidemiology and genetics of cluster headache. Lancet Neurol 3:279–283
Favier I, Haan J (2005) Chronic cluster headache: a review. J Headache Pain 6:3–9
Rosales RL, Arimura K, Takenaga S, Osame M (1996) Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection. Muscle Nerve 19:488–496
Silberstein S, Mathew N, Saper J, Jenkins S (2000) Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group. Headache 40:445–450
Brin MF, Swope DM, o’Brian C et al (2000) Botox for migraine: doubleblind, placebo-controlled, region-specific evaluation. Cephalalgia 20:421–422
Mathew NT, Frishberg BM, Gawel M et al (2005) Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache 45:293–307
Farinelli I, Coloprisco G, De Filippis S, Martelletti P (2006) Long-term benefits of botulinum toxin type A (BOTOX) in chronic daily headache: a five-year long experience. J Headache Pain 7:407–412
Porta M, Camerlingo M (2005) Headache and botulinum toxin. J Headache Pain 6:325–327
Goadsby PJ, Edvinsson L (1993) The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 33:48–56
Freund BJ, Schwartz M (2000) The use of Botulinum toxin-A in the treatment of refractory cluster headache: case reports. Cephalalgia 20:325–331
Smuts JA, Barnard PWA (2000) Botulinum Toxin type A in the treatment of headache syndromes: a clinical report on 79 patients. Cephalalgia 20:332
Robbins L (2001) Botulinum Toxin A (Botox) for cluster headache: 6 cases. Cephalalgia 21:499–500
The International Classification of Headache Disorders, 2nd edn. Headache Classification Subcommittee of the International Headache Society (2004) Cephalalgia 24:44–48
Solomon S, Lipton RB, Newman LC (1990) Nuchal features of cluster headache. Headache 30:347–349
Verslegers WR, Pickut BA, De Deyn PP (2006) Paroxysmal neuralgic upper cervical pain attacks: The lower syndrome of cluster headache. Clin Neurol Neurosurg 108:737–743
Hardebo JE (1994) How cluster headache is explained as an intracavernous inflammatory process lesioning sympathetic fibers. Headache 34:125–131
Sprenger T, Valet M, Hammes M et al (2004) Hypothalamic activation in trigeminal autonomic cephalgia: functional imaging of an atypical case. Cephalalgia 24:753–757
May A, Bahra A, Buchel C et al (1998) Hypothalamic activation in cluster headache attacks. Lancet 352:275–278
May A, Ashburner J, Buchel C et al (1999) Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med 5:836–838
Franzini A, Ferroli P, Leone M, Broggi G (2003) Stimulation of the posterior hypothalamus for treatment of chronic intractable cluster headaches: first reported series. Neurosurgery 52:1095–1099; discussion 1099–1101
Leone M, Franzini A, Broggi G, Bussone G (2003) Hypothalamic deep brain stimulation for intractable chronic cluster headache: a 3-year follow-up. Neurol Sci 24Suppl 2:S143–145
Schoenen J, Di Clemente L, Vandenheede M et al (2005) Hypothalamic stimulation in chronic cluster headache: a pilot study of efficacy and mode of action. Brain 128:940–947
Malick A, Strassman RM, Burstein R (2000) Trigeminohypothalamic and reticulohypothalamic tract neurons in the upper cervical spinal cord and caudal medulla of the rat. J Neurophysiol 84:2078–2112
Aoki KR (2005) Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. NeuroToxicology 26:785–793
Wiegand H, Erdmann G, Wellhoner HH (1976) 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedebergs Arch Pharmacol 292:161–165
Welch MJ, Purkiss JR, Foster KA (2000) Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon 38:245–258
Durham PL, Cady R (2004) Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache 44:35–42; discussion 42–33
Nilsson Remal AIM, Laudon Meyer E, Cordonnier C, Goadsby PJ (2003) Placebo response in cluster headache trials: a review. Cephalalgia 23:504–510
Monstad I, Krabbe A, Micieli G et al (1995) Preemptive oral treatment with sumatriptan during a cluster period. Headache 35:607–613
Steiner TJ, Hering R, Couturier EGM et al (1997). Double-blind placebo-controlled trial of lithium in episodic cluster headache. Cephalalgia 17:673–675
Nilsson Remahl AI, Ansjon R, Lind F, Waldenlind E (2002) Hyperbaric oxygen treatment of active cluster headache: a double blind placebo-controlled cross-over study. Cephalalgia 22:730–739.
Cittadini E, May A, Straube A et al (2006) Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study. Arch Neurol 63:1537–1542
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sostak, P., Krause, P., Förderreuther, S. et al. Botulinum toxin type-A therapy in cluster headache: an open study. J Headache Pain 8, 236–241 (2007). https://doi.org/10.1007/s10194-007-0400-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10194-007-0400-0
Keywords
- Cluster headache
- Botulinum toxin-A
- Headache/drug therapy
- Treatment outcome